Literature DB >> 2272820

Pharmacokinetics of tiaprofenic acid after oral administration in fasting patients during and between migraine attacks.

L A Pini1, M Bertolotti, G Bergonzini, L Casalgrandi, L Giroldi, E Sternieri.   

Abstract

This study examined the pharmacokinetics of 300 mg of tiaprofenic acid, a NSAID belonging to the 2-arylpropionic class, as a single oral dose, in 10 migraine patients during and out of migraine attacks. Plasma concentration of tiaprofenic acid was determined by HPLC analysis. Drug absorption appeared to be the same during and out of migraine attacks (absorption half life: during attack, 0.249 +/- 0.122 hr; out of attack, 0.249 +/- 0.105 hr; maximum plasma concentration: during attack, 37.8 +/- 9.8 ug/ml; out of attack, 40.1 +/- 13.2 ug/ml). The other pharmacokinetic parameters evaluated were not affected by headache attacks as well. We conclude that tiaprofenic acid absorption and metabolism are not affected by migraine attacks. Also, our data suggest that tiaprofenic acid might be useful in the treatment of migraine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2272820     DOI: 10.1111/j.1526-4610.1990.hed3010672.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  2 in total

Review 1.  Clinical pharmacokinetics of tiaprofenic acid and its enantiomers.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

2.  Comparative pharmacokinetics of senkyunolide I in a rat model of migraine versus normal controls.

Authors:  Yi-Han Wang; Yan-Long Hong; Yi Feng; De-Sheng Xu; Shuang Liang; Xiao Lin; Lan Shen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-02-10       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.